GRAIL, LLC (GRAL NASDAQ) stock market data APIs
$98.8895
8.78(8.9%)
as of February 4, 2026
Try our APIs with
free plan!
GRAIL, LLC Financial Data Overview
Price chart is built with
Anychart
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, it develops minimal residual disease post-diagnostic tests. The company was incorporated in 2015 and is headquartered in Menlo Park, California.
Prev. Close
98.8895
Open
107.6669
High
107.6684
Low
95.6917
52 wk Range
20.44-118.84
Market Cap
4 110 M
Shares Outstanding
38 982 K
Revenue
142 M
EPS
-2.46
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with GRAIL, LLC (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get GRAIL, LLC data using free add-ons & libraries
Get GRAIL, LLC Fundamental Data
GRAIL, LLC Fundamental data includes:
- Net Revenue: 142 M
- EBITDA: -349 376 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-12
- EPS/Forecast: -3.26
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
GRAIL, LLC News
New
Hims & Hers Scores A Cancer Deal With Grail, But Shares Reverse Lower
Hims stock reversed lower Wednesday after the telehealth giant said it will begin selling Grail's multi-cancer detection test, Galleri, on its website. The blood test can screen for more than 50 types...
Cheap high flyer healthcare stocks - high momentum and low valuation
[Health Care Medical Stock Market Industry Sector Wall Street Buildings 3d Illustration] iQoncept/iStock via Getty Images As earnings season ramps up and geopolitical tensions keep affecting the mark...
GRAIL Submits FDA PMA for Galleri Multi-Cancer Early Detection Test
GRAIL, Inc. GRAL announced the submission of the final module of its premarket approval application to the FDA for the Galleri multi-cancer early detection (MCED) test. The FDA had previously granted ...
The Most Expensive Question Investors Ask
I’ve been around a long time and seen many cycles in the stock market. There is a moment every investor recognizes. When you open your account and notice a decline, the same question often arises. D...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
